Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Written in Blood

Research from recent issues of Blood
Efficacy Data Show Potential for Dual Inventory With Cold-, Room Temperature-Stored Platelet Transfusions
Katie Robinson
Caplacizumab Improves ADAMTS13 Recovery in Patients with iTTP
Lara C. Pullen, PhD
High-Dose Oral Vitamin A Before HCT May Reduce GVHD in Children
Katie Robinson
Elevated White Blood Cell Counts, Hematocrit Levels Linked to Thrombotic Events in Polycythemia Vera
Lara C. Pullen, PhD
Unique Molecular Subtypes within BCR::ABL1-Postive ALL Show Prognostic Relevance
Khylia Marshall
CD20 Loss a Cause of Mosunetuzumab Resistance in Non-Hodgkin Lymphoma
Ruth Jessen Hickman, MD
In the Long Run, Ibrutinib Brings Disease Control, but Cardiac Risks, in Older Patients with Untreated CLL
Thomas R. Collins
Detection of Persistent Free Light Chain Using Mass Spectrometry Is a Sensitive Marker of OS in AL Amyloidosis
Anna Azvolinsky, PhD
Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%
Lara C. Pullen, PhD
Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure
Lara C. Pullen, PhD
Time-Limited Ibrutinib, CD19-Directed CAR-T Combo Shows Efficacy for Poor-Risk, R/R Mantle Cell Lymphoma
Khylia Marshall
Inotuzumab as a Bridging Therapy to Eradicate MRD Improves OS in Patients With ALL
Khylia Marshall
Serum TARC Levels Increased Years Prior to Hodgkin Lymphoma Diagnosis
Leah Lawrence
Real-World Studies Show Poorer Outcomes for Tafasitamab, Lenalidomide in R/R LBCL
Ruth Jessen Hickman, MD
Study Validates Surrogate Markers for EMZL Therapy, Shortens Future Trial Duration
Khylia Marshall
Biomarkers Related to VTE Risk Decrease Within Weeks of Stopping Combined Hormonal Contraception
Anna Azvolinsky, PhD
Study Characterizes Rare Genetic Platelet Disorder Associated with Blood Cancers
Deborah Levenson
TP53 Status May Hint at Acute Myeloid Leukemia Prognosis
Lara C. Pullen, PhD
No Change in Platelet Count Threshold of Patients With ITP Treated With Aspirin
Khylia Marshall
Children With T-ALL Show Similar Treatment Outcomes Independent of ETP Status
Katie Robinson

Advertisement

Connect with us:

CURRENT ISSUE
April 2024

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement